4.81B
Market cap
4.72x
Current P/E
5.03x
Forward P/E

About

Health care
Sector
Drug Manufacturers - General
Industry

Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzys, Renflexis, and Hadlima, as well as two oncology products, including Ontruzant and Aybintio.

Similar securities

Based on sector and market capitalization

Report issue